Table 2 Baseline demographic and clinical characteristics of patients on long-term allopurinol
Patients with ICD-9 code for gout + new allopurinol prescription (n = 643)
Age (years) on 1 Jan 199967.9 (9.7)
Male, n (%)639 (99.4%)
Race, n (%)
    White275 (42.8%)
    Non-white9 (1.4%)
    Unknown359 (55.8%)
Charlson Comorbidity Index (maximum over study period)2.5 (2.3)
Inpatient stays/year0.33 (0.61)
Inpatient stays/year with gout as primary diagnosis0.011 (0.06)
Primary care visits/year3.6 (2.6)
Rheumatology visits/year0.14 (0.49)
Other outpatient visits/year13.0 (12.2)
Days/year with any outpatient visits14.3 (12.3)
Means test, n (%)
    AN309 (48.1%)
    AS232 (36.1%)
    C102 (15.9%)
Percentage service connected (maximum over study period)17.6 (30.1)
  • Data are presented as mean (SD) except where noted otherwise.

  • Means test categories defined as follows: AN, most needy but not service connected; AS, most needy and service connected; C, not “most needy”.